JPRN-UMIN000047449招募中未知
evaluation of ventilation distribution during stepwise recruitment maneuver and decremental PEEP trial using electrical impedance tomography - Optimal PEEP selected by SRM and EIT
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)no indication of mechanical ventilation 2)hemodynamically unstable with mean blood pressure less than 55 mmHg 3)Not suitable for EIT attachment 4)patients with medical history of pneumothorax
研究者
相似试验
进行中（未招募）
1 期
Etude de phase II ouverte évaluant en fonction du polymorphisme du CYP2D6, le taux de réponse biologique au traitement par tamoxifène (TAM) administré en situation pré-opératoire chez des patientes présentant un cancer du sein non métastatique RH+ - TAMCancer du seinEUCTR2008-007652-10-FRCentre René Gauducheau
已完成
4 期
The onset of action and safety of Dyston in glabellar lines improvementGlabellar frown lines.Changes in skin textureR23.4IRCT20180515039672N3Imen Vaccine Alborz184
已完成
1 期
Chloroquine effects on Plasmodium vivax isolate HMPBS02-PvMalaria infectionInfection - Studies of infection and infectious agentsACTRN12616000174482QIMR Berghofer Medical Research Institute24
进行中（未招募）
不适用
Phase I Study to Determine the Maximum Tolerated Dose of NC-6004 in Patients with Solid Tumours - Phase I dose-escalation Study of NC-6001 in patients with solid tumoursHistologically-confirmed advanced solid tumours for which no standard therapy exists or has failed therapyEUCTR2005-004827-20-GBanoCarrier Co., Ltd.30
招募中
不适用
Phase 1 study to determine the maximum tolerated dose and to assess the safety, pharmacokinetics, and efficacy of AVI-3207 Inj. in patients with neovascular age-related macular degeneratioDiseases of the eye and adnexaKCT0004887Avixgen9